Form 8-K - Current report:
SEC Accession No. 0000950170-22-011505
Filing Date
2022-06-10
Accepted
2022-06-10 17:15:22
Documents
12
Period of Report
2022-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20220610.htm   iXBRL 8-K 76660
  Complete submission text file 0000950170-22-011505.txt   198471

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bolt-20220610_lab.xml EX-101.LAB 14110
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bolt-20220610_pre.xml EX-101.PRE 10377
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bolt-20220610.xsd EX-101.SCH 2480
6 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20220610_htm.xml XML 4942
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 221009869
SIC: 2834 Pharmaceutical Preparations